Topics
November/December 2018 | Subfocus: The Best Of Retina
A Review of All Things Retina
Looking back at some of the field's exciting developments over the past 12 months.
Michele Corry
July 10, 2026
Opus Genetics Provides BEST1 Program Update
July 9, 2026
Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema
Teva, Samsung Bioepis Sign Canadian Commercialization Agreement for Aflibercept Biosimilar
Atsena Selects Lead Clinical Candidate for Stargardt Disease Gene Therapy
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
